Two patients with recurrent medulloblastomas were treated with combined oral and intra-venous chemotherapy followed by intra-arterial BCNU. The 7 days course of oral and intra-venous chemotherapy consisted of CCNU and Procarbazin orally and Vincristine intra-venously (PCV), repeated after 6 weeks.
Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma
β Scribed by Victor A. Levin; Pamela S. Vestnys; Michael S. Edwards; William M. Wara; Dorcas Fulton; Geoffrey Barger; Margaret Seager; Charles B. Wilson
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 606 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Purpose Merkel cell carcinoma (MCC) is a rare and aggressive malignancy that originates within the extremities in about 40% of cases. Treatment approaches to this tumor have not been standardized. The purpose of this study was to examine treatment approaches to extremity MCC and to
## RESULTS. Postoperative survival was significantly improved in the later groups for patients with Stage I, II, III, and IV disease. A multivariate analysis of prognostic factors revealed that the time period during which the gastrectomy was performed was an independent predictor of survival. ##
We report survival data for Danish center-treated cystic fibrosis (CF) patients, covering the period 1974-1 993 and using cross-sectional cumulative survival probability based on annual age-specific mortality rates. Analyses by age and by years after diagnosis were made. No significant differences w